T1	Chemical 0 10	Cytostatic
T2	Chemical 15 38	anti-angiogenic effects
T3	Chemical 42 54	temsirolimus
T4	Disease 69 89	mantle cell lymphoma
T5	Disease 90 110	Mantle cell lymphoma
T6	Disease 150 179	B-cell non-Hodgkin's lymphoma
T10	Disease 296 310	remission rate
T12	Chemical 369 381	temsirolimus
T13	Chemical 385 399	mTOR inhibitor
T15	Disease 458 461	MCL
T17	Chemical 504 516	temsirolimus
T18	Disease 588 598	lymph node
T19	Chemical 651 663	temsirolimus
T20	Chemical 716 728	temsirolimus
T22	Disease 772 789	cell cycle arrest
T23	Chemical 877 887	cytostatic
T24	Chemical 896 908	temsirolimus
T25	Chemical 916 937	antiangiogenic effect
T27	Chemical 988 992	VEGF
T29	Disease 1045 1059	fibrotic areas
T30	Disease 1077 1104	post-necrotic tissue repair
T31	Chemical 1131 1143	temsirolimus
T32	Chemical 1159 1171	temsirolimus
T34	Chemical 1212 1222	cytostatic
T35	Chemical 1227 1250	anti-angiogenic effects
T36	Chemical 1256 1267	dual effect
T37	Chemical 1271 1283	temsirolimus
T40	Disease 1367 1370	MCL
